Home The efficacy of topical Marham-e-Akbar in chronic atopic dermatitis – an open-label interventional study
Article
Licensed
Unlicensed Requires Authentication

The efficacy of topical Marham-e-Akbar in chronic atopic dermatitis – an open-label interventional study

  • Shaikh Imran , Mohd Khalid ORCID logo EMAIL logo , Nazim Husain ORCID logo , Mohd Qudrathullah Khan and Shalina Shaikh
Published/Copyright: February 25, 2022

Abstract

Objectives

Chronic atopic dermatitis (AD) is an inflammatory skin condition marked by intense pruritus, dry skin, and severe impact on the life quality of the patients. Conventionally, it is managed by using emollients, calcineurin inhibitors, and topical corticosteroids. In Unani medicine, eminent scholars advocated many drug formulations including topical Marham-e-Akbar for effective healing of AD but scientific evidence is scarce. Hence, this study was designed.

Methods

This was a single-arm clinical trial conducted on 30 participants aged 18–65 years suffering from chronic AD after obtaining written informed consent. The trial intervention was Marham-e-Akbar consisting of Murdār Sang (Plumbi oxidum); Sindūr (red lead); olive oil (Olea europaea oil); Kath (Acacia catechu extract); Safeda Kāshgari (Zinc oxide); Sirka (vinegar); and Phitkirī (alum) to be applied twice daily for 42 days. The objective parameters were SCORAD and DLQI, while the subjective parameters included itching, scaling, and erythema assessed on a customized VAS scale and 4-point Likert scale.

Results

The pre-post analysis inferred statistically significant attenuation in subjective parameters (itching, scaling, and erythema) and objective scales (SCORAD) and (DLQI) with p<0.001.

Conclusions

The study findings deduced that Marham-e-Akbar is effective in the amelioration of chronic atopic dermatitis and quality of life of the patients as well.


Corresponding author: Mohd Khalid, Department of Medicine (Unani), Luqman Unani Medical College Hospital and Research Center, Bijapur, Karnataka 586101, India, E-mail:

Acknowledgments

Authors are thankful to the management of Luqman Unani Medical College, Bijapur, Karnataka, India for providing financial support in execution of this trial.

  1. Research funding: Luqman Unani Medical College, Bijapur, Karnataka, India.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study was initiated only after ethical approval by the Institutional Ethics Committee (Ref. No. BJP/LUMC/PG/IEC/04/2018–19/MOALIJAT/03) and registration with Clinical Trial Registry-India (CTRI/2020/03/024360).

References

1. Jonathan, MS, Paller, AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118–27, https://doi.org/10.1016/j.jaci.2003.09.033.Search in Google Scholar PubMed

2. Kumar, S, Nayak, CS, Padhi, T, Rao, G, Rao, A, Sharma, VK, et al.. Epidemiological pattern of psoriasis, vitiligo and atopic dermatitis in India: Hospital-based point prevalence. Indian Dermatol Online J 2014;5 (Suppl 1):S6–8, https://doi.org/10.4103/2229-5178.144499.Search in Google Scholar PubMed PubMed Central

3. Rönmark, EP, Ekerljung, L, Lötvall, J, Wennergren, G, Rönmark, E, Torén, K, et al.. Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden. Br J Dermatol 2012;166:1301–8, https://doi.org/10.1111/j.1365-2133.2012.10904.x.Search in Google Scholar PubMed

4. Sandström Falk, MH, Faergemann, J. Atopic dermatitis in adults: does it disappear with age? Acta Derm Venereol 2006;86:135–9, https://doi.org/10.2340/00015555-0096.Search in Google Scholar PubMed

5. Williams, HC. Atopic dermatitis. N Engl J Med 2005;352:2314–24, https://doi.org/10.1056/nejmcp042803.Search in Google Scholar

6. Leung, DYM, Boguniewicz, M, Howell, MD, Nomura, I, Hamid, QA. New insights into atopic dermatitis. J Clin Invest 2004;113:651–7, https://doi.org/10.1172/jci21060.Search in Google Scholar

7. Palmer, CNA, Irvine, AD, Terron-Kwiatkowski, A, Zhao, Y, Liao, H, Lee, SP, et al.. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441–6, https://doi.org/10.1038/ng1767.Search in Google Scholar PubMed

8. Vinding, GR, Zarchi, K, Ibler, KS, Miller, IM, Ellervik, C, Jemec, GBE. Is adult atopic eczema more common than we think? – A population-based study in Danish adults. Acta Derm Venereol 2014;94:480–2, https://doi.org/10.2340/00015555-1761.Search in Google Scholar PubMed

9. Kosse, RC, Bouvy, ML, Daanen, M, de Vries, TW, Koster, ES. Adolescents’ perspectives on atopic dermatitis treatment-experiences, preferences, and beliefs. JAMA dermatology 2018;154:824–7, https://doi.org/10.1001/jamadermatol.2018.1096.Search in Google Scholar PubMed PubMed Central

10. van Zuuren, EJ, Fedorowicz, Z, Christensen, R, Lavrijsen, A, Arents, BW. Emollients and moisturisers for eczema. Cochrane Database Syst. Rev. 2017;2:CD012119, https://doi.org/10.1002/14651858.cd012119.pub2.Search in Google Scholar

11. Schäfer, T, Nienhaus, A, Vieluf, D, Berger, J, Ring, J. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001;145:100–4, https://doi.org/10.1046/j.1365-2133.2001.04290.x.Search in Google Scholar

12. Aumeeruddy, MZ, Aumeeruddy-Elalfi, Z, Neetoo, H, Zengin, G, Blom van Staden, A, Fibrich, B, et al.. Pharmacological activities, chemical profile, and physicochemical properties of raw and commercial honey. Biocatal Agric Biotechnol 2019;18:101005, https://doi.org/10.1016/j.bcab.2019.01.043.Search in Google Scholar

13. Al-Qamri, N. Ghina Muna, 1st ed., New Delhi: CCRUM; 2008. 492–3 pp.Search in Google Scholar

14. Standard Unani treatment guidelines, 1st ed., New Dehli: Central Council for Research in Unani Medicine (CCRUM); 2012, vol. II. 152–4 pp.Search in Google Scholar

15. Al-Ghani, N. Qarābādīn Najm al-Ghani. New Delhi: Central Council For Research in Unani Medicine; 2020. 1037 p.Search in Google Scholar

16. Ibn, Sīnā. Al-Qanoon fit Tib (Arabic). New Delhi: Hamdard Publication, 1999, vol. 4. 169 p.Search in Google Scholar

17. Kanwar, A. Adult-onset atopic dermatitis. Indian J Dermatol 2016;61:662, https://doi.org/10.4103/0019-5154.193679.Search in Google Scholar

18. Mollerup, A, Veien, NK, Johansen, JD. An analysis of gender differences in patients with hand eczema – everyday exposures, severity, and consequences. Contact Dermatitis 2014;71:21–30, https://doi.org/10.1111/cod.12206.Search in Google Scholar

19. Osman, M, Hansell, AL, Simpson, CR, Hollowell, J, Helms, PJ. Gender-specific presentations for asthma, allergic rhinitis and eczema in primary care. Prim Care Respir J 2007;16:28–35, https://doi.org/10.3132/pcrj.2007.00006.Search in Google Scholar

20. Johannisson, A, Pontén, A, Svensson, Å. Prevalence, incidence and predictive factors for hand eczema in young adults - a follow-up study. BMC Dermatol 2013;13:14, https://doi.org/10.1186/1471-5945-13-14.Search in Google Scholar

21. Katta, R, Schlichte, M. Diet and dermatitis: Food triggers. J Clin Aesthet Dermatol 2014;7:30–6.Search in Google Scholar

22. Martorell Aragonés, A. Implicación etiológica de los alimentos en la dermatitis atópica: Datos en contra. Allergol Immunopathol 2002;30:120–6.10.1016/S0301-0546(02)79104-0Search in Google Scholar

23. Uehara, M, Kimura, C. Descendant family history of atopic dermatitis. Acta Derm Venereol 1993;73:62–3, https://doi.org/10.2340/00015555736263.Search in Google Scholar PubMed

24. Razi, Z. Kitab al-Hawi, 1st ed., New Delhi: CCRUM; 2007, vol. XXI. 72 p. Part 1.Search in Google Scholar

25. Baytar, I. Al-Jami al-Mufradat lil Advia wa al-Aghziya. New Delhi: CCRUM; 1999, vol. 3. 271–5 pp.Search in Google Scholar

26. Bagdadi, IH. Kitab al-Mukhtarat fi al-Tibb, 2nd ed., New Delhi: CCRUM; 2005, vol. II. 226–7 pp.Search in Google Scholar

27. Haleem, A. Mufradat-e-Azizi, 1st ed., New Delhi: CCRUM; 2009. 51 p.Search in Google Scholar

28. Zaki, M, Fatima, L, Begum, W. Shibb-e-Yamani (alum) and its therapeutic effects in Unani system of medicine: a review. Global J Res Anal 2020;9:15–7.Search in Google Scholar

29. Ghani, N. Khazain-ul-Adviya. New Delhi: Idara Kitab-us-Shifa; 2011, 918–21 pp.Search in Google Scholar

30. Anjum, A, Firdose, KF. A comprehensive review of vinegar in Unani literature: an evidence-based approach. J Emerg Technol Innov Res 2020;7:156–61.Search in Google Scholar

31. Johnston, CS, Gaas, CA. Vinegar: medicinal uses and antiglycemic effect. MedGenMed 2006;8:61.Search in Google Scholar

32. Bhat, SV, Akhtar, R, Amin, T. An overview on the biological production of vinegar. Int J Fermented Foods 2014;3:139, https://doi.org/10.5958/2321-712x.2014.01315.5.Search in Google Scholar

33. Abdul, M. Bustan al-Mufradat. 1st ed., New Delhi: Idara Kitabul Shifa; 2002, vol. 339–340. 572 p.Search in Google Scholar

34. Kumar, HD, Laxmidhar, S. A review on phytochemical and pharmacological of eucalyptus globulus : a multipurpose tree. Int J Res Ayurveda Pharm 2011;2:1527–30.Search in Google Scholar

35. Kabeeruddin, M. Makhzan-ul-Mufradat, 1st ed., New Delhi: Eijaz publishing house; 2007, 562–3 pp.Search in Google Scholar

36. de Araújo Vilar, D, de Araújo Vilar, MS, de Lima e Moura, TFA, Raffin, FN, de Oliveira, MR, de Oliveira Franco, CF, et al.. Traditional uses, chemical constituents, and biological activities of Bixa orellana L.: a review. Sci World J 2014;2014:1–11, https://doi.org/10.1155/2014/857292.Search in Google Scholar PubMed PubMed Central

37. Bashir, F, Akhtar, J. Asl Khalis (Honey) a multi-functional drug of Unani system of medicine. Int J Unani Integr Med. 2019;3:35−9.10.33545/2616454X.2019.v3.i3a.93Search in Google Scholar

38. Ahmed, S, Sulaiman, SA, Baig, AA, Ibrahim, M, Liaqat, S, Fatima, S, et al.. Honey as a potential natural antioxidant medicine: an insight into its molecular mechanisms of action. Oxid Med Cell Longev 2018;2018:1–19, https://doi.org/10.1155/2018/8367846.Search in Google Scholar PubMed PubMed Central

Received: 2021-10-15
Revised: 2021-12-28
Accepted: 2022-01-12
Published Online: 2022-02-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines
  4. Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics
  5. Original Articles
  6. Predicting drug–drug interactions by electrochemically driven cytochrome P450 3A4 reactions
  7. Evaluation of the stability of furosemide in tablet form during six-month storage in spaceflight and peculiarities of its pharmacokinetics and pharmacodynamics under conditions of anti-orthostatic hypokinesia
  8. CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers
  9. The markers of the organic acidemias and their ratios in healthy neonates in Serbian population
  10. Kolaviron ameliorates chronic unpredictable mild stress-induced anxiety and depression: involvement of the HPA axis, antioxidant defense system, cholinergic, and BDNF signaling
  11. The efficacy of topical Marham-e-Akbar in chronic atopic dermatitis – an open-label interventional study
  12. In vitro metabolic biomodulation of irinotecan to increase potency and reduce dose-limiting toxicity by inhibition of SN-38 glucuronide formation
  13. Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity
  14. Synergistic anti-cancer effects of Nigella sativa seed oil and conventional cytotoxic agent against human breast cancer
  15. Short Communication
  16. MTHFR c.665C>T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dmpt-2021-0195/html
Scroll to top button